Table 2.
Sr No | Template | Interacting residues in recent Cryo_EM structure in open conformation state of hERG | Complementary GRIND contours | Interacting residues in close conformation state of hERG | Complementary GRIND contours |
---|---|---|---|---|---|
1 | MK-499 | Met_645, Gly_648, Leu_622 | DRY-N1, DRY-N1 |
Tyr_652, Phe_656 | DRY-DRY TIP-TIP |
2 | E4031 | Ser_624, Ser_649, Lue_622 | DRY-O Dry-N1 |
Ser_624, Phe_656 | DRY-N1 DRY-DRY |
3 | Dofetilide | Met_645, Tyr_652, Thr_623, Ser_649 | DRY-DRY DRY-N1 |
Ser624, Ser649 | DRY-N1 |
4 | Trimethoprim | Ser_624, Thr_623 | DRY-N1 | Tyr_623, Ser_624 | DRY-N1 |
5 | 9OH-Risperidone | Tyr_652, Ser_624 | DRY-DRY DRY-N1 |
Ser_649, Tyr_652 | DRY-DRY DRY-N1 |
6 | Benperidol | Ser_621, Tyr_652 | DRY-N1 DRY-DRY |
Ser_649, Tyr_652 Phe_656 | DRY-N1 DRY-DRY DRY-TIP |
7 | Droperidol | Tyr_652, Ser_624 | DRY-DRY DRY-N1 |
Ser_624, Ser_649 | DRY-N1 |
8 | Norastemizole | Ser_624, Tyr_652 | DRY-O DRY-DRY |
Ser_624, Lue_622 Gly_648 | DRY-N1 DRY-O |
9 | Vesnarinone | Leu_622, Tyr_652 | DRY-O DRY-DRY |
Phe_656, Ser_649 | DRY-DRY DRY-N1 |
10 | BMLC_1835_4 | Ser_621, Tyr_652 | DRY-N1 DRY-TIP |
Leu_622, Thr_623 | DRY-N1 |
11 | Risperidone | Ser_624, Tyr_652 | DRY-N1 DRY-DRY |
Ser_649 | DRY-N1 |
12 | Haloperidol | Phe_624, Tyr_652 | DRY-DRY DRY-N1 |
Ser_624, Phe_656 | DRY-N1 DRY-DRY |
13 | Glycerol-nonivamide | Tyr_652, Ser_624 | DRY-N1, DRY-DRY |
Ser_649 | DRY-N1 |